Qilian International Holding Group Limited (BGM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($683.65K) by net assets ($392.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BGM stock market capitalisation for the company's overall valuation and market capitalisation.
Qilian International Holding Group Limited - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Qilian International Holding Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Qilian International Holding Group Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qilian International Holding Group Limited ranked by their cash flow conversion efficiency. Explore earnings quality score of Qilian International Holding Group Limit to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Immobile
WAR:GKI
|
0.215x |
|
Chung Fu Tex-International Corp
TW:1435
|
-0.010x |
|
Serrano 61 Desarrollo SOCIMI SA
MC:YSRR
|
-0.002x |
|
RiTdisplay Corp
TW:8104
|
0.022x |
|
Fulin Plastic Industry Cayman Holding Co Ltd
TW:1341
|
0.049x |
|
Catur Sentosa Adiprana Tbk
JK:CSAP
|
0.036x |
|
Tsang Yow Industrial Co Ltd
TW:1568
|
0.033x |
|
Nasmedia Co. Ltd
KQ:089600
|
-0.051x |
Annual Cash Flow Conversion Efficiency for Qilian International Holding Group Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Qilian International Holding Group Limited from 2017 to 2025. View BGM share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $392.14 Million | $-2.37 Million | -0.006x | -149.02% |
| 2024-09-30 | $44.09 Million | $544.24K | 0.012x | +75.34% |
| 2023-09-30 | $44.35 Million | $312.21K | 0.007x | -96.94% |
| 2022-09-30 | $54.96 Million | $12.65 Million | 0.230x | +3681.28% |
| 2021-09-30 | $56.67 Million | $345.03K | 0.006x | -96.54% |
| 2020-09-30 | $28.84 Million | $5.08 Million | 0.176x | +786.70% |
| 2019-09-30 | $22.64 Million | $-580.20K | -0.026x | -110.23% |
| 2018-09-30 | $17.72 Million | $4.44 Million | 0.250x | +27.54% |
| 2017-09-30 | $13.66 Million | $2.68 Million | 0.196x | -- |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufactu… Read more